Literature DB >> 28620098

Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

Kevin H Toomer1, Thomas R Malek1,2.   

Abstract

Cytokine signaling is indispensable for regulatory T-cell (Treg) development in the thymus, and also influences the homeostasis, phenotypic diversity, and function of Tregs in the periphery. Because Tregs are required for establishment and maintenance of immunological self-tolerance, investigating the role of cytokines in Treg biology carries therapeutic potential in the context of autoimmune disease. This review discusses the potent and diverse influences of interleukin (IL)-2 signaling on the Treg compartment, an area of knowledge that has led to the use of low-dose IL-2 as a therapy to reregulate autoaggressive immune responses. Evidence suggesting Treg-specific impacts of the cytokines transforming growth factor β (TGF-β), IL-7, thymic stromal lymphopoietin (TSLP), IL-15, and IL-33 is also presented. Finally, we consider the technical challenges and knowledge limitations that must be overcome to bring other cytokine-based, Treg-targeted therapies into clinical use.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28620098      PMCID: PMC5830895          DOI: 10.1101/cshperspect.a028597

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  149 in total

Review 1.  Regulatory T cells and immune tolerance in the intestine.

Authors:  Oliver J Harrison; Fiona M Powrie
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 2.  Phenotypical and functional specialization of FOXP3+ regulatory T cells.

Authors:  Daniel J Campbell; Meghan A Koch
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

3.  Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cells.

Authors:  Wim Pierson; Bénédicte Cauwe; Antonia Policheni; Susan M Schlenner; Dean Franckaert; Julien Berges; Stephanie Humblet-Baron; Susann Schönefeldt; Marco J Herold; David Hildeman; Andreas Strasser; Philippe Bouillet; Li-Fan Lu; Patrick Matthys; Antonio A Freitas; Rita J Luther; Casey T Weaver; James Dooley; Daniel H D Gray; Adrian Liston
Journal:  Nat Immunol       Date:  2013-07-14       Impact factor: 25.606

Review 4.  Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.

Authors:  Charlotte R Grant; Rodrigo Liberal; Giorgina Mieli-Vergani; Diego Vergani; Maria Serena Longhi
Journal:  Autoimmun Rev       Date:  2014-10-16       Impact factor: 9.754

Review 5.  Regulatory T cells: mechanisms of differentiation and function.

Authors:  Steven Z Josefowicz; Li-Fan Lu; Alexander Y Rudensky
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

Review 6.  Induced CD4+Foxp3+ regulatory T cells in immune tolerance.

Authors:  Angelina M Bilate; Juan J Lafaille
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

7.  Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters.

Authors:  Markus Feuerer; Laura Herrero; Daniela Cipolletta; Afia Naaz; Jamie Wong; Ali Nayer; Jongsoon Lee; Allison B Goldfine; Christophe Benoist; Steven Shoelson; Diane Mathis
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Molecular mechanisms of treg-mediated T cell suppression.

Authors:  Angelika Schmidt; Nina Oberle; Peter H Krammer
Journal:  Front Immunol       Date:  2012-03-21       Impact factor: 7.561

Review 9.  The role of IL-33 in rheumatic diseases.

Authors:  Lihua Duan; Jie Chen; Feili Gong; Guixiu Shi
Journal:  Clin Dev Immunol       Date:  2013-09-15

10.  Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice.

Authors:  Mamdouh A K Sedhom; Mélanie Pichery; Jenna R Murdoch; Benoit Foligné; Nathalie Ortega; Sylvain Normand; Kirsten Mertz; Devika Sanmugalingam; Lea Brault; Teddy Grandjean; Emma Lefrancais; Padraic G Fallon; Valérie Quesniaux; Laurent Peyrin-Biroulet; Gieri Cathomas; Tobias Junt; Mathias Chamaillard; Jean-Philippe Girard; Bernhard Ryffel
Journal:  Gut       Date:  2012-11-21       Impact factor: 23.059

View more
  22 in total

1.  LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity.

Authors:  Yanyan Wang; Xingrong Du; Jun Wei; Lingyun Long; Haiyan Tan; Cliff Guy; Yogesh Dhungana; Chenxi Qian; Geoffrey Neale; Yang-Xin Fu; Jiyang Yu; Junmin Peng; Hongbo Chi
Journal:  Cell Res       Date:  2019-03-25       Impact factor: 25.617

Review 2.  Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives.

Authors:  Ken-Ichi Matsuoka
Journal:  Int J Hematol       Date:  2017-12-12       Impact factor: 2.490

3.  IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.

Authors:  Guanglin Cui; Zhenfeng Li; Jingli Ren; Aping Yuan
Journal:  Virchows Arch       Date:  2019-05-06       Impact factor: 4.064

4.  A novel immune prognostic model of non-M3 acute myeloid leukemia.

Authors:  Hong Ding; Yu Feng; Juan Xu; Zhimei Lin; Jingcao Huang; Fangfang Wang; Hongmei Luo; Yuhan Gao; Xinyu Zhai; Xin Wang; Li Zhang; Ting Niu; Yuhuan Zheng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

Review 5.  Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues.

Authors:  Kai Yang
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 6.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

7.  Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo.

Authors:  Jorge Gallego-Valle; Sergio Gil-Manso; Ana Pita; Esther Bernaldo-de-Quirós; Rocío López-Esteban; Marta Martínez-Bonet; Verónica Astrid Pérez-Fernández; Ramón Pérez-Caballero; Carlos Pardo; Juan-Miguel Gil-Jaurena; Rafael Correa-Rocha; Marjorie Pion
Journal:  Biomedicines       Date:  2021-04-23

8.  Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.

Authors:  Nirmala Chandralega Kampan; Mutsa Tatenda Madondo; Orla M McNally; Andrew N Stephens; Michael A Quinn; Magdalena Plebanski
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

9.  Comparative Analysis of Thymic and Blood Treg in Myasthenia Gravis: Thymic Epithelial Cells Contribute to Thymic Immunoregulatory Defects.

Authors:  Frédérique Truffault; Dani Nazzal; Julien Verdier; Angeline Gradolatto; Elie Fadel; Régine Roussin; Bruno Eymard; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

10.  Yersinia Pseudotuberculosis Modulates Regulatory T Cell Stability via Injection of Yersinia Outer Proteins in a Type III Secretion System-Dependent Manner.

Authors:  Ahmed Elfiky; Agnes Bonifacius; Joern Pezoldt; Maria Pasztoi; Paweena Chaoprasid; Pooja Sadana; Nagla El-Sherbeeny; Magda Hagras; Andrea Scrima; Petra Dersch; Jochen Huehn
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2018-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.